ACCELERON PHARMA INC. Deferred Tax Assets, Net of Valuation Allowance
ACCELERON PHARMA INC. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2021-02-25
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-27 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-25 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-02 |